nodes	percent_of_prediction	percent_of_DWPC	metapath
Dipyridamole—ADA—pleura—thymus cancer	0.0551	0.112	CbGeAlD
Dipyridamole—PDE5A—pulmonary artery—thymus cancer	0.0269	0.055	CbGeAlD
Dipyridamole—Ischaemia—Octreotide—thymus cancer	0.0259	0.0521	CcSEcCtD
Dipyridamole—Rectal tenesmus—Octreotide—thymus cancer	0.0254	0.051	CcSEcCtD
Dipyridamole—Stomach ache—Octreotide—thymus cancer	0.0222	0.0447	CcSEcCtD
Dipyridamole—Proctalgia—Octreotide—thymus cancer	0.0201	0.0405	CcSEcCtD
Dipyridamole—Renal pain—Octreotide—thymus cancer	0.018	0.0362	CcSEcCtD
Dipyridamole—Anorectal discomfort—Octreotide—thymus cancer	0.0173	0.0348	CcSEcCtD
Dipyridamole—Cholelithiasis—Octreotide—thymus cancer	0.0152	0.0306	CcSEcCtD
Dipyridamole—PDE6A—pituitary gland—thymus cancer	0.0145	0.0295	CbGeAlD
Dipyridamole—Peptic ulcer—Octreotide—thymus cancer	0.0141	0.0284	CcSEcCtD
Dipyridamole—Abdominal cramps—Octreotide—thymus cancer	0.014	0.0282	CcSEcCtD
Dipyridamole—PDE6B—hematopoietic system—thymus cancer	0.0117	0.0239	CbGeAlD
Dipyridamole—Injection site pain—Octreotide—thymus cancer	0.0116	0.0233	CcSEcCtD
Dipyridamole—Breast pain—Octreotide—thymus cancer	0.0108	0.0218	CcSEcCtD
Dipyridamole—PDE11A—epithelium—thymus cancer	0.00995	0.0203	CbGeAlD
Dipyridamole—PDE7A—hematopoietic system—thymus cancer	0.00971	0.0198	CbGeAlD
Dipyridamole—Injection site reaction—Octreotide—thymus cancer	0.00939	0.0189	CcSEcCtD
Dipyridamole—PRUNE—cardiac atrium—thymus cancer	0.00936	0.0191	CbGeAlD
Dipyridamole—Eructation—Octreotide—thymus cancer	0.00928	0.0187	CcSEcCtD
Dipyridamole—PRUNE—pituitary gland—thymus cancer	0.00914	0.0187	CbGeAlD
Dipyridamole—PDE8B—neck—thymus cancer	0.00907	0.0185	CbGeAlD
Dipyridamole—PDE1C—thyroid gland—thymus cancer	0.00874	0.0178	CbGeAlD
Dipyridamole—PDE6B—lymphoid tissue—thymus cancer	0.00825	0.0168	CbGeAlD
Dipyridamole—PDE1C—lung—thymus cancer	0.00794	0.0162	CbGeAlD
Dipyridamole—PRUNE—thyroid gland—thymus cancer	0.00788	0.0161	CbGeAlD
Dipyridamole—PDE6D—bone marrow—thymus cancer	0.00763	0.0156	CbGeAlD
Dipyridamole—PDE6D—thyroid gland—thymus cancer	0.00761	0.0155	CbGeAlD
Dipyridamole—PDE6B—thyroid gland—thymus cancer	0.00749	0.0153	CbGeAlD
Dipyridamole—Hot flush—Octreotide—thymus cancer	0.00733	0.0148	CcSEcCtD
Dipyridamole—Menopausal symptoms—Octreotide—thymus cancer	0.00727	0.0146	CcSEcCtD
Dipyridamole—PRUNE—lung—thymus cancer	0.00716	0.0146	CbGeAlD
Dipyridamole—Anaphylactoid reaction—Octreotide—thymus cancer	0.00708	0.0143	CcSEcCtD
Dipyridamole—Arthritis—Octreotide—thymus cancer	0.00705	0.0142	CcSEcCtD
Dipyridamole—PDE11A—thyroid gland—thymus cancer	0.00696	0.0142	CbGeAlD
Dipyridamole—PDE6D—lung—thymus cancer	0.00692	0.0141	CbGeAlD
Dipyridamole—Gastrointestinal haemorrhage—Octreotide—thymus cancer	0.00686	0.0138	CcSEcCtD
Dipyridamole—PDE7A—lymphoid tissue—thymus cancer	0.00683	0.014	CbGeAlD
Dipyridamole—PDE6B—lung—thymus cancer	0.0068	0.0139	CbGeAlD
Dipyridamole—PDE3B—hematopoietic system—thymus cancer	0.0066	0.0135	CbGeAlD
Dipyridamole—Abdominal pain upper—Octreotide—thymus cancer	0.00626	0.0126	CcSEcCtD
Dipyridamole—Cramp muscle—Octreotide—thymus cancer	0.00617	0.0124	CcSEcCtD
Dipyridamole—PDE6G—lung—thymus cancer	0.00609	0.0124	CbGeAlD
Dipyridamole—Bronchospasm—Octreotide—thymus cancer	0.00583	0.0117	CcSEcCtD
Dipyridamole—Sweating increased—Octreotide—thymus cancer	0.00577	0.0116	CcSEcCtD
Dipyridamole—Abdominal discomfort—Octreotide—thymus cancer	0.00568	0.0114	CcSEcCtD
Dipyridamole—PDE1C—lymph node—thymus cancer	0.00543	0.0111	CbGeAlD
Dipyridamole—PDE7B—thyroid gland—thymus cancer	0.00542	0.0111	CbGeAlD
Dipyridamole—PDE2A—cardiac atrium—thymus cancer	0.00538	0.011	CbGeAlD
Dipyridamole—PDE2A—pituitary gland—thymus cancer	0.00525	0.0107	CbGeAlD
Dipyridamole—ADA—hematopoietic system—thymus cancer	0.005	0.0102	CbGeAlD
Dipyridamole—PDE7B—lung—thymus cancer	0.00493	0.0101	CbGeAlD
Dipyridamole—PRUNE—lymph node—thymus cancer	0.0049	0.01	CbGeAlD
Dipyridamole—PDE3B—pituitary gland—thymus cancer	0.00489	0.00999	CbGeAlD
Dipyridamole—Bradycardia—Octreotide—thymus cancer	0.00483	0.00972	CcSEcCtD
Dipyridamole—Rhinitis—Octreotide—thymus cancer	0.00475	0.00957	CcSEcCtD
Dipyridamole—Hepatitis—Octreotide—thymus cancer	0.00474	0.00955	CcSEcCtD
Dipyridamole—PDE6D—lymph node—thymus cancer	0.00473	0.00966	CbGeAlD
Dipyridamole—Hypoaesthesia—Octreotide—thymus cancer	0.00472	0.0095	CcSEcCtD
Dipyridamole—Pharyngitis—Octreotide—thymus cancer	0.00471	0.00948	CcSEcCtD
Dipyridamole—PDE8A—cardiac atrium—thymus cancer	0.00461	0.00942	CbGeAlD
Dipyridamole—PDE10A—thyroid gland—thymus cancer	0.00453	0.00924	CbGeAlD
Dipyridamole—PDE2A—thyroid gland—thymus cancer	0.00453	0.00924	CbGeAlD
Dipyridamole—PDE8A—pituitary gland—thymus cancer	0.00451	0.0092	CbGeAlD
Dipyridamole—PDE1B—thyroid gland—thymus cancer	0.00449	0.00916	CbGeAlD
Dipyridamole—Tinnitus—Octreotide—thymus cancer	0.00442	0.0089	CcSEcCtD
Dipyridamole—Cardiac disorder—Octreotide—thymus cancer	0.0044	0.00886	CcSEcCtD
Dipyridamole—Flushing—Octreotide—thymus cancer	0.0044	0.00886	CcSEcCtD
Dipyridamole—PDE8B—thyroid gland—thymus cancer	0.00432	0.00882	CbGeAlD
Dipyridamole—Immune system disorder—Octreotide—thymus cancer	0.00428	0.00862	CcSEcCtD
Dipyridamole—Arrhythmia—Octreotide—thymus cancer	0.00424	0.00853	CcSEcCtD
Dipyridamole—PDE3B—bone marrow—thymus cancer	0.00423	0.00864	CbGeAlD
Dipyridamole—Alopecia—Octreotide—thymus cancer	0.00419	0.00844	CcSEcCtD
Dipyridamole—PDE6G—lymph node—thymus cancer	0.00416	0.0085	CbGeAlD
Dipyridamole—PDE5A—hematopoietic system—thymus cancer	0.00414	0.00846	CbGeAlD
Dipyridamole—PDE2A—lung—thymus cancer	0.00411	0.0084	CbGeAlD
Dipyridamole—PDE10A—lung—thymus cancer	0.00411	0.0084	CbGeAlD
Dipyridamole—Flatulence—Octreotide—thymus cancer	0.00407	0.00819	CcSEcCtD
Dipyridamole—Tension—Octreotide—thymus cancer	0.00405	0.00816	CcSEcCtD
Dipyridamole—PDE3A—hematopoietic system—thymus cancer	0.00403	0.00823	CbGeAlD
Dipyridamole—Nervousness—Octreotide—thymus cancer	0.00401	0.00807	CcSEcCtD
Dipyridamole—Back pain—Octreotide—thymus cancer	0.00399	0.00804	CcSEcCtD
Dipyridamole—Muscle spasms—Octreotide—thymus cancer	0.00397	0.00799	CcSEcCtD
Dipyridamole—PDE8B—lung—thymus cancer	0.00392	0.00801	CbGeAlD
Dipyridamole—PDE8A—thyroid gland—thymus cancer	0.00389	0.00793	CbGeAlD
Dipyridamole—Tremor—Octreotide—thymus cancer	0.00387	0.00779	CcSEcCtD
Dipyridamole—PDE3B—lung—thymus cancer	0.00383	0.00782	CbGeAlD
Dipyridamole—Ill-defined disorder—Octreotide—thymus cancer	0.00383	0.00771	CcSEcCtD
Dipyridamole—Anaemia—Octreotide—thymus cancer	0.00382	0.00768	CcSEcCtD
Dipyridamole—PDE5A—epithelium—thymus cancer	0.00379	0.00773	CbGeAlD
Dipyridamole—PDE1A—thyroid gland—thymus cancer	0.00376	0.00768	CbGeAlD
Dipyridamole—Malaise—Octreotide—thymus cancer	0.00372	0.00749	CcSEcCtD
Dipyridamole—Vertigo—Octreotide—thymus cancer	0.00371	0.00747	CcSEcCtD
Dipyridamole—Syncope—Octreotide—thymus cancer	0.0037	0.00745	CcSEcCtD
Dipyridamole—Palpitations—Octreotide—thymus cancer	0.00365	0.00734	CcSEcCtD
Dipyridamole—Loss of consciousness—Octreotide—thymus cancer	0.00363	0.0073	CcSEcCtD
Dipyridamole—Cough—Octreotide—thymus cancer	0.0036	0.00725	CcSEcCtD
Dipyridamole—Convulsion—Octreotide—thymus cancer	0.00358	0.0072	CcSEcCtD
Dipyridamole—Hypertension—Octreotide—thymus cancer	0.00356	0.00718	CcSEcCtD
Dipyridamole—PDE8A—lung—thymus cancer	0.00353	0.00721	CbGeAlD
Dipyridamole—ADA—lymphoid tissue—thymus cancer	0.00352	0.00719	CbGeAlD
Dipyridamole—Chest pain—Octreotide—thymus cancer	0.00352	0.00708	CcSEcCtD
Dipyridamole—Arthralgia—Octreotide—thymus cancer	0.00352	0.00708	CcSEcCtD
Dipyridamole—Myalgia—Octreotide—thymus cancer	0.00352	0.00708	CcSEcCtD
Dipyridamole—Anxiety—Octreotide—thymus cancer	0.0035	0.00705	CcSEcCtD
Dipyridamole—Unspecified disorder of skin and subcutaneous tissue—Octreotide—thymus cancer	0.00349	0.00703	CcSEcCtD
Dipyridamole—SLC29A1—hematopoietic system—thymus cancer	0.00348	0.0071	CbGeAlD
Dipyridamole—Discomfort—Octreotide—thymus cancer	0.00347	0.00699	CcSEcCtD
Dipyridamole—Dry mouth—Octreotide—thymus cancer	0.00344	0.00692	CcSEcCtD
Dipyridamole—PDE1A—lung—thymus cancer	0.00342	0.00697	CbGeAlD
Dipyridamole—PDE7B—lymph node—thymus cancer	0.00337	0.00688	CbGeAlD
Dipyridamole—Anaphylactic shock—Octreotide—thymus cancer	0.00337	0.00678	CcSEcCtD
Dipyridamole—Oedema—Octreotide—thymus cancer	0.00337	0.00678	CcSEcCtD
Dipyridamole—Shock—Octreotide—thymus cancer	0.00332	0.00667	CcSEcCtD
Dipyridamole—Nervous system disorder—Octreotide—thymus cancer	0.0033	0.00665	CcSEcCtD
Dipyridamole—Thrombocytopenia—Octreotide—thymus cancer	0.0033	0.00664	CcSEcCtD
Dipyridamole—Tachycardia—Octreotide—thymus cancer	0.00329	0.00662	CcSEcCtD
Dipyridamole—Skin disorder—Octreotide—thymus cancer	0.00327	0.00659	CcSEcCtD
Dipyridamole—Hyperhidrosis—Octreotide—thymus cancer	0.00326	0.00656	CcSEcCtD
Dipyridamole—ADA—bone marrow—thymus cancer	0.00321	0.00654	CbGeAlD
Dipyridamole—ADA—thyroid gland—thymus cancer	0.0032	0.00653	CbGeAlD
Dipyridamole—PDE4A—thyroid gland—thymus cancer	0.00312	0.00636	CbGeAlD
Dipyridamole—Musculoskeletal discomfort—Octreotide—thymus cancer	0.00307	0.00618	CcSEcCtD
Dipyridamole—PDE3A—cardiac atrium—thymus cancer	0.00306	0.00625	CbGeAlD
Dipyridamole—Paraesthesia—Octreotide—thymus cancer	0.00303	0.00609	CcSEcCtD
Dipyridamole—Dyspnoea—Octreotide—thymus cancer	0.003	0.00605	CcSEcCtD
Dipyridamole—Somnolence—Octreotide—thymus cancer	0.003	0.00603	CcSEcCtD
Dipyridamole—Dyspepsia—Octreotide—thymus cancer	0.00297	0.00597	CcSEcCtD
Dipyridamole—Gastrointestinal disorder—Octreotide—thymus cancer	0.00291	0.00586	CcSEcCtD
Dipyridamole—Fatigue—Octreotide—thymus cancer	0.00291	0.00585	CcSEcCtD
Dipyridamole—ADA—lung—thymus cancer	0.0029	0.00593	CbGeAlD
Dipyridamole—Pain—Octreotide—thymus cancer	0.00288	0.0058	CcSEcCtD
Dipyridamole—ABCC5—cardiac atrium—thymus cancer	0.00288	0.00588	CbGeAlD
Dipyridamole—PDE4A—lung—thymus cancer	0.00283	0.00578	CbGeAlD
Dipyridamole—PDE2A—lymph node—thymus cancer	0.00281	0.00574	CbGeAlD
Dipyridamole—PDE10A—lymph node—thymus cancer	0.00281	0.00574	CbGeAlD
Dipyridamole—ABCC5—pituitary gland—thymus cancer	0.00281	0.00574	CbGeAlD
Dipyridamole—PDE1B—lymph node—thymus cancer	0.00279	0.00569	CbGeAlD
Dipyridamole—Feeling abnormal—Octreotide—thymus cancer	0.00278	0.00559	CcSEcCtD
Dipyridamole—Gastrointestinal pain—Octreotide—thymus cancer	0.00276	0.00555	CcSEcCtD
Dipyridamole—PDE8B—lymph node—thymus cancer	0.00268	0.00548	CbGeAlD
Dipyridamole—Urticaria—Octreotide—thymus cancer	0.00268	0.00539	CcSEcCtD
Dipyridamole—Abdominal pain—Octreotide—thymus cancer	0.00266	0.00536	CcSEcCtD
Dipyridamole—PDE5A—thyroid gland—thymus cancer	0.00265	0.00541	CbGeAlD
Dipyridamole—SLC29A1—cardiac atrium—thymus cancer	0.00264	0.00539	CbGeAlD
Dipyridamole—ABCC4—hematopoietic system—thymus cancer	0.00263	0.00536	CbGeAlD
Dipyridamole—PDE3B—lymph node—thymus cancer	0.00262	0.00535	CbGeAlD
Dipyridamole—SLC29A1—pituitary gland—thymus cancer	0.00258	0.00527	CbGeAlD
Dipyridamole—PDE3A—thyroid gland—thymus cancer	0.00258	0.00526	CbGeAlD
Dipyridamole—Hypersensitivity—Octreotide—thymus cancer	0.00248	0.005	CcSEcCtD
Dipyridamole—SLC29A1—lymphoid tissue—thymus cancer	0.00245	0.005	CbGeAlD
Dipyridamole—ABCC5—bone marrow—thymus cancer	0.00243	0.00496	CbGeAlD
Dipyridamole—ABCC5—thyroid gland—thymus cancer	0.00242	0.00495	CbGeAlD
Dipyridamole—Asthenia—Octreotide—thymus cancer	0.00242	0.00487	CcSEcCtD
Dipyridamole—PDE8A—lymph node—thymus cancer	0.00241	0.00493	CbGeAlD
Dipyridamole—PDE5A—lung—thymus cancer	0.00241	0.00491	CbGeAlD
Dipyridamole—Pruritus—Octreotide—thymus cancer	0.00238	0.0048	CcSEcCtD
Dipyridamole—PDE3A—lung—thymus cancer	0.00234	0.00478	CbGeAlD
Dipyridamole—PDE1A—lymph node—thymus cancer	0.00234	0.00477	CbGeAlD
Dipyridamole—Diarrhoea—Octreotide—thymus cancer	0.00231	0.00464	CcSEcCtD
Dipyridamole—SLC29A1—bone marrow—thymus cancer	0.00223	0.00455	CbGeAlD
Dipyridamole—Dizziness—Octreotide—thymus cancer	0.00223	0.00449	CcSEcCtD
Dipyridamole—SLC29A1—thyroid gland—thymus cancer	0.00222	0.00454	CbGeAlD
Dipyridamole—ABCC5—lung—thymus cancer	0.0022	0.00449	CbGeAlD
Dipyridamole—Vomiting—Octreotide—thymus cancer	0.00214	0.00431	CcSEcCtD
Dipyridamole—Rash—Octreotide—thymus cancer	0.00212	0.00428	CcSEcCtD
Dipyridamole—Dermatitis—Octreotide—thymus cancer	0.00212	0.00427	CcSEcCtD
Dipyridamole—Headache—Octreotide—thymus cancer	0.00211	0.00425	CcSEcCtD
Dipyridamole—SLC29A1—lung—thymus cancer	0.00202	0.00413	CbGeAlD
Dipyridamole—Nausea—Octreotide—thymus cancer	0.002	0.00403	CcSEcCtD
Dipyridamole—ADA—lymph node—thymus cancer	0.00199	0.00406	CbGeAlD
Dipyridamole—PDE4A—lymph node—thymus cancer	0.00194	0.00395	CbGeAlD
Dipyridamole—ABCC4—bone marrow—thymus cancer	0.00168	0.00344	CbGeAlD
Dipyridamole—ABCC4—thyroid gland—thymus cancer	0.00168	0.00343	CbGeAlD
Dipyridamole—PDE5A—lymph node—thymus cancer	0.00165	0.00336	CbGeAlD
Dipyridamole—PDE3A—lymph node—thymus cancer	0.0016	0.00327	CbGeAlD
Dipyridamole—ABCC4—lung—thymus cancer	0.00153	0.00311	CbGeAlD
Dipyridamole—ABCC5—lymph node—thymus cancer	0.00151	0.00307	CbGeAlD
Dipyridamole—SLC29A1—lymph node—thymus cancer	0.00138	0.00282	CbGeAlD
Dipyridamole—ABCC4—lymph node—thymus cancer	0.00104	0.00213	CbGeAlD
Dipyridamole—ABCB1—hematopoietic system—thymus cancer	0.000914	0.00187	CbGeAlD
Dipyridamole—ABCB1—epithelium—thymus cancer	0.000836	0.00171	CbGeAlD
Dipyridamole—ABCB1—pituitary gland—thymus cancer	0.000678	0.00138	CbGeAlD
Dipyridamole—ABCB1—lymphoid tissue—thymus cancer	0.000644	0.00131	CbGeAlD
Dipyridamole—ABCB1—bone marrow—thymus cancer	0.000586	0.0012	CbGeAlD
Dipyridamole—ABCB1—thyroid gland—thymus cancer	0.000585	0.00119	CbGeAlD
Dipyridamole—ABCB1—lung—thymus cancer	0.000531	0.00108	CbGeAlD
Dipyridamole—ABCB1—lymph node—thymus cancer	0.000363	0.000742	CbGeAlD
Dipyridamole—PDE1C—DAP12 signaling—AKT1—thymus cancer	6.74e-05	0.00501	CbGpPWpGaD
Dipyridamole—PDE2A—Signaling Pathways—MAML2—thymus cancer	6.68e-05	0.00497	CbGpPWpGaD
Dipyridamole—PDE1C—Innate Immune System—KIT—thymus cancer	6.46e-05	0.0048	CbGpPWpGaD
Dipyridamole—PDE2A—Hemostasis—IL2—thymus cancer	6.4e-05	0.00476	CbGpPWpGaD
Dipyridamole—PDE1C—Signaling by FGFR in disease—AKT1—thymus cancer	6.34e-05	0.00471	CbGpPWpGaD
Dipyridamole—PDE1C—DAP12 interactions—AKT1—thymus cancer	6.34e-05	0.00471	CbGpPWpGaD
Dipyridamole—PDE1C—Signaling by EGFR—AKT1—thymus cancer	6.28e-05	0.00467	CbGpPWpGaD
Dipyridamole—PDE1C—Signaling by EGFR in Cancer—AKT1—thymus cancer	6.23e-05	0.00463	CbGpPWpGaD
Dipyridamole—PDE1C—Signaling by PDGF—AKT1—thymus cancer	6.2e-05	0.00461	CbGpPWpGaD
Dipyridamole—PDE7B—Signaling Pathways—MAML2—thymus cancer	6.11e-05	0.00454	CbGpPWpGaD
Dipyridamole—PDE6B—Signaling by Wnt—AKT1—thymus cancer	6.09e-05	0.00453	CbGpPWpGaD
Dipyridamole—PDE6A—Signaling by Wnt—AKT1—thymus cancer	6.09e-05	0.00453	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling by NGF—KIT—thymus cancer	6.03e-05	0.00448	CbGpPWpGaD
Dipyridamole—PDE11A—Signaling Pathways—MAML2—thymus cancer	5.68e-05	0.00422	CbGpPWpGaD
Dipyridamole—PDE7A—Signaling Pathways—MAML2—thymus cancer	5.68e-05	0.00422	CbGpPWpGaD
Dipyridamole—PDE1C—NGF signalling via TRKA from the plasma membrane—AKT1—thymus cancer	5.62e-05	0.00418	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling by NGF—KIT—thymus cancer	5.51e-05	0.0041	CbGpPWpGaD
Dipyridamole—PDE1A—Immune System—CYLD—thymus cancer	5.46e-05	0.00406	CbGpPWpGaD
Dipyridamole—PDE11A—Hemostasis—IL2—thymus cancer	5.44e-05	0.00405	CbGpPWpGaD
Dipyridamole—PDE6A—Disease—KIT—thymus cancer	5.31e-05	0.00395	CbGpPWpGaD
Dipyridamole—PDE6B—Disease—KIT—thymus cancer	5.31e-05	0.00395	CbGpPWpGaD
Dipyridamole—PDE1C—Signaling Pathways—MAML2—thymus cancer	5.27e-05	0.00392	CbGpPWpGaD
Dipyridamole—PDE6G—Signaling Pathways—MAML2—thymus cancer	5.19e-05	0.00386	CbGpPWpGaD
Dipyridamole—PDE10A—Signaling Pathways—MAML2—thymus cancer	5.06e-05	0.00376	CbGpPWpGaD
Dipyridamole—PDE1C—Immune System—CD8A—thymus cancer	5.01e-05	0.00372	CbGpPWpGaD
Dipyridamole—PDE1B—Immune System—CYLD—thymus cancer	5e-05	0.00371	CbGpPWpGaD
Dipyridamole—ADA—Circadian rythm related genes—TP53—thymus cancer	4.97e-05	0.0037	CbGpPWpGaD
Dipyridamole—PDE1C—Innate Immune System—CD4—thymus cancer	4.94e-05	0.00367	CbGpPWpGaD
Dipyridamole—PDE10A—Hemostasis—IL2—thymus cancer	4.85e-05	0.00361	CbGpPWpGaD
Dipyridamole—PDE5A—Hemostasis—IL2—thymus cancer	4.85e-05	0.00361	CbGpPWpGaD
Dipyridamole—PDE1C—Signaling by NGF—AKT1—thymus cancer	4.32e-05	0.00321	CbGpPWpGaD
Dipyridamole—PDE8A—GPCR downstream signaling—IL2—thymus cancer	4.15e-05	0.00309	CbGpPWpGaD
Dipyridamole—PDE8B—GPCR downstream signaling—IL2—thymus cancer	4.15e-05	0.00309	CbGpPWpGaD
Dipyridamole—PDE2A—Hemostasis—TP53—thymus cancer	4.11e-05	0.00306	CbGpPWpGaD
Dipyridamole—PDE6A—Disease—CD4—thymus cancer	4.06e-05	0.00302	CbGpPWpGaD
Dipyridamole—PDE6B—Disease—CD4—thymus cancer	4.06e-05	0.00302	CbGpPWpGaD
Dipyridamole—PDE2A—GPCR downstream signaling—IL2—thymus cancer	4.05e-05	0.00301	CbGpPWpGaD
Dipyridamole—ABCC5—Disease—MAML2—thymus cancer	4.01e-05	0.00298	CbGpPWpGaD
Dipyridamole—PDE1A—Disease—MAML2—thymus cancer	4.01e-05	0.00298	CbGpPWpGaD
Dipyridamole—PDE6G—Signaling by Wnt—AKT1—thymus cancer	3.92e-05	0.00292	CbGpPWpGaD
Dipyridamole—PDE1A—Downstream signaling of activated FGFR—AKT1—thymus cancer	3.88e-05	0.00288	CbGpPWpGaD
Dipyridamole—PDE8B—Signaling by GPCR—IL2—thymus cancer	3.77e-05	0.0028	CbGpPWpGaD
Dipyridamole—PDE8A—Signaling by GPCR—IL2—thymus cancer	3.77e-05	0.0028	CbGpPWpGaD
Dipyridamole—PDE1C—Immune System—KIT—thymus cancer	3.76e-05	0.0028	CbGpPWpGaD
Dipyridamole—PDE6A—Signaling Pathways—KIT—thymus cancer	3.72e-05	0.00277	CbGpPWpGaD
Dipyridamole—PDE6B—Signaling Pathways—KIT—thymus cancer	3.72e-05	0.00277	CbGpPWpGaD
Dipyridamole—PDE7B—GPCR downstream signaling—IL2—thymus cancer	3.7e-05	0.00275	CbGpPWpGaD
Dipyridamole—PDE2A—Signaling by GPCR—IL2—thymus cancer	3.67e-05	0.00273	CbGpPWpGaD
Dipyridamole—PDE1B—Disease—MAML2—thymus cancer	3.66e-05	0.00272	CbGpPWpGaD
Dipyridamole—PDE1A—Downstream signal transduction—AKT1—thymus cancer	3.64e-05	0.00271	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling by FGFR—AKT1—thymus cancer	3.63e-05	0.0027	CbGpPWpGaD
Dipyridamole—ABCC4—Platelet activation, signaling and aggregation—IL2—thymus cancer	3.61e-05	0.00269	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling by ERBB2—AKT1—thymus cancer	3.61e-05	0.00268	CbGpPWpGaD
Dipyridamole—PDE1A—DAP12 signaling—AKT1—thymus cancer	3.59e-05	0.00267	CbGpPWpGaD
Dipyridamole—PDE1B—Downstream signaling of activated FGFR—AKT1—thymus cancer	3.55e-05	0.00264	CbGpPWpGaD
Dipyridamole—PDE11A—Hemostasis—TP53—thymus cancer	3.49e-05	0.0026	CbGpPWpGaD
Dipyridamole—PDE1C—Disease—KIT—thymus cancer	3.47e-05	0.00258	CbGpPWpGaD
Dipyridamole—PDE2A—Hemostasis—AKT1—thymus cancer	3.47e-05	0.00258	CbGpPWpGaD
Dipyridamole—PDE11A—GPCR downstream signaling—IL2—thymus cancer	3.44e-05	0.00256	CbGpPWpGaD
Dipyridamole—PDE7A—GPCR downstream signaling—IL2—thymus cancer	3.44e-05	0.00256	CbGpPWpGaD
Dipyridamole—PDE1A—Innate Immune System—KIT—thymus cancer	3.44e-05	0.00256	CbGpPWpGaD
Dipyridamole—PDE6G—Disease—KIT—thymus cancer	3.42e-05	0.00255	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling by FGFR in disease—AKT1—thymus cancer	3.38e-05	0.00251	CbGpPWpGaD
Dipyridamole—PDE1A—DAP12 interactions—AKT1—thymus cancer	3.38e-05	0.00251	CbGpPWpGaD
Dipyridamole—PDE7B—Signaling by GPCR—IL2—thymus cancer	3.36e-05	0.0025	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling by EGFR—AKT1—thymus cancer	3.35e-05	0.00249	CbGpPWpGaD
Dipyridamole—PDE1B—Downstream signal transduction—AKT1—thymus cancer	3.33e-05	0.00248	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling by EGFR in Cancer—AKT1—thymus cancer	3.32e-05	0.00247	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling by FGFR—AKT1—thymus cancer	3.32e-05	0.00247	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling by PDGF—AKT1—thymus cancer	3.3e-05	0.00246	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling by ERBB2—AKT1—thymus cancer	3.3e-05	0.00245	CbGpPWpGaD
Dipyridamole—PDE1B—DAP12 signaling—AKT1—thymus cancer	3.28e-05	0.00244	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling Pathways—MAML2—thymus cancer	3.28e-05	0.00244	CbGpPWpGaD
Dipyridamole—ABCB1—Allograft Rejection—IL2—thymus cancer	3.26e-05	0.00243	CbGpPWpGaD
Dipyridamole—PDE8B—Signaling Pathways—KIT—thymus cancer	3.16e-05	0.00235	CbGpPWpGaD
Dipyridamole—PDE8A—Signaling Pathways—KIT—thymus cancer	3.16e-05	0.00235	CbGpPWpGaD
Dipyridamole—PDE1B—Innate Immune System—KIT—thymus cancer	3.15e-05	0.00234	CbGpPWpGaD
Dipyridamole—PDE3B—Hemostasis—IL2—thymus cancer	3.14e-05	0.00233	CbGpPWpGaD
Dipyridamole—PDE11A—Signaling by GPCR—IL2—thymus cancer	3.12e-05	0.00232	CbGpPWpGaD
Dipyridamole—PDE7A—Signaling by GPCR—IL2—thymus cancer	3.12e-05	0.00232	CbGpPWpGaD
Dipyridamole—PDE10A—Hemostasis—TP53—thymus cancer	3.11e-05	0.00232	CbGpPWpGaD
Dipyridamole—PDE5A—Hemostasis—TP53—thymus cancer	3.11e-05	0.00232	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling by FGFR in disease—AKT1—thymus cancer	3.09e-05	0.0023	CbGpPWpGaD
Dipyridamole—PDE1B—DAP12 interactions—AKT1—thymus cancer	3.09e-05	0.0023	CbGpPWpGaD
Dipyridamole—PDE2A—Signaling Pathways—KIT—thymus cancer	3.08e-05	0.00229	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling Pathways—MAML2—thymus cancer	3.07e-05	0.00228	CbGpPWpGaD
Dipyridamole—PDE10A—GPCR downstream signaling—IL2—thymus cancer	3.07e-05	0.00228	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling by EGFR—AKT1—thymus cancer	3.06e-05	0.00228	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling by EGFR in Cancer—AKT1—thymus cancer	3.03e-05	0.00226	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling by PDGF—AKT1—thymus cancer	3.02e-05	0.00225	CbGpPWpGaD
Dipyridamole—PDE1A—NGF signalling via TRKA from the plasma membrane—AKT1—thymus cancer	2.99e-05	0.00222	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—MAML2—thymus cancer	2.98e-05	0.00222	CbGpPWpGaD
Dipyridamole—PDE11A—Hemostasis—AKT1—thymus cancer	2.95e-05	0.00219	CbGpPWpGaD
Dipyridamole—PDE1C—Signaling by GPCR—IL2—thymus cancer	2.9e-05	0.00215	CbGpPWpGaD
Dipyridamole—PDE1C—Immune System—CD4—thymus cancer	2.88e-05	0.00214	CbGpPWpGaD
Dipyridamole—PDE3A—Hemostasis—IL2—thymus cancer	2.86e-05	0.00213	CbGpPWpGaD
Dipyridamole—PDE7B—Signaling Pathways—KIT—thymus cancer	2.82e-05	0.0021	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—MAML2—thymus cancer	2.81e-05	0.00209	CbGpPWpGaD
Dipyridamole—PDE10A—Signaling by GPCR—IL2—thymus cancer	2.78e-05	0.00207	CbGpPWpGaD
Dipyridamole—PDE1B—NGF signalling via TRKA from the plasma membrane—AKT1—thymus cancer	2.74e-05	0.00203	CbGpPWpGaD
Dipyridamole—PDE1A—Hemostasis—IL2—thymus cancer	2.69e-05	0.002	CbGpPWpGaD
Dipyridamole—PDE1A—Immune System—CD8A—thymus cancer	2.67e-05	0.00198	CbGpPWpGaD
Dipyridamole—PDE1C—Disease—CD4—thymus cancer	2.65e-05	0.00197	CbGpPWpGaD
Dipyridamole—PDE1C—Immune System—IL2—thymus cancer	2.65e-05	0.00197	CbGpPWpGaD
Dipyridamole—PDE5A—Hemostasis—AKT1—thymus cancer	2.63e-05	0.00196	CbGpPWpGaD
Dipyridamole—PDE10A—Hemostasis—AKT1—thymus cancer	2.63e-05	0.00196	CbGpPWpGaD
Dipyridamole—PDE1A—Innate Immune System—CD4—thymus cancer	2.63e-05	0.00196	CbGpPWpGaD
Dipyridamole—PDE11A—Signaling Pathways—KIT—thymus cancer	2.62e-05	0.00195	CbGpPWpGaD
Dipyridamole—PDE7A—Signaling Pathways—KIT—thymus cancer	2.62e-05	0.00195	CbGpPWpGaD
Dipyridamole—PDE6G—Disease—CD4—thymus cancer	2.62e-05	0.00195	CbGpPWpGaD
Dipyridamole—PDE6A—Signaling Pathways—IL2—thymus cancer	2.62e-05	0.00195	CbGpPWpGaD
Dipyridamole—PDE6B—Signaling Pathways—IL2—thymus cancer	2.62e-05	0.00195	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—MAML2—thymus cancer	2.57e-05	0.00191	CbGpPWpGaD
Dipyridamole—PDE1C—Innate Immune System—AKT1—thymus cancer	2.46e-05	0.00183	CbGpPWpGaD
Dipyridamole—PDE1B—Hemostasis—IL2—thymus cancer	2.46e-05	0.00183	CbGpPWpGaD
Dipyridamole—PDE1B—Immune System—CD8A—thymus cancer	2.44e-05	0.00181	CbGpPWpGaD
Dipyridamole—PDE1C—Signaling Pathways—KIT—thymus cancer	2.43e-05	0.00181	CbGpPWpGaD
Dipyridamole—PDE1B—Innate Immune System—CD4—thymus cancer	2.41e-05	0.00179	CbGpPWpGaD
Dipyridamole—PDE6G—Signaling Pathways—KIT—thymus cancer	2.4e-05	0.00178	CbGpPWpGaD
Dipyridamole—PDE10A—Signaling Pathways—KIT—thymus cancer	2.34e-05	0.00174	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling by NGF—AKT1—thymus cancer	2.3e-05	0.00171	CbGpPWpGaD
Dipyridamole—PDE8A—GPCR downstream signaling—AKT1—thymus cancer	2.25e-05	0.00167	CbGpPWpGaD
Dipyridamole—PDE8B—GPCR downstream signaling—AKT1—thymus cancer	2.25e-05	0.00167	CbGpPWpGaD
Dipyridamole—PDE8B—Signaling Pathways—IL2—thymus cancer	2.23e-05	0.00166	CbGpPWpGaD
Dipyridamole—PDE8A—Signaling Pathways—IL2—thymus cancer	2.23e-05	0.00166	CbGpPWpGaD
Dipyridamole—PDE2A—GPCR downstream signaling—AKT1—thymus cancer	2.19e-05	0.00163	CbGpPWpGaD
Dipyridamole—PDE2A—Signaling Pathways—IL2—thymus cancer	2.17e-05	0.00161	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling by NGF—AKT1—thymus cancer	2.1e-05	0.00156	CbGpPWpGaD
Dipyridamole—PDE8A—Signaling by GPCR—AKT1—thymus cancer	2.04e-05	0.00152	CbGpPWpGaD
Dipyridamole—PDE8B—Signaling by GPCR—AKT1—thymus cancer	2.04e-05	0.00152	CbGpPWpGaD
Dipyridamole—ABCB1—HIF-1-alpha transcription factor network—AKT1—thymus cancer	2.04e-05	0.00152	CbGpPWpGaD
Dipyridamole—PDE6A—Disease—AKT1—thymus cancer	2.03e-05	0.00151	CbGpPWpGaD
Dipyridamole—PDE6B—Disease—AKT1—thymus cancer	2.03e-05	0.00151	CbGpPWpGaD
Dipyridamole—PDE3B—Hemostasis—TP53—thymus cancer	2.02e-05	0.0015	CbGpPWpGaD
Dipyridamole—PDE7B—GPCR downstream signaling—AKT1—thymus cancer	2.01e-05	0.00149	CbGpPWpGaD
Dipyridamole—PDE1A—Immune System—KIT—thymus cancer	2e-05	0.00149	CbGpPWpGaD
Dipyridamole—PDE2A—Signaling by GPCR—AKT1—thymus cancer	1.99e-05	0.00148	CbGpPWpGaD
Dipyridamole—PDE7B—Signaling Pathways—IL2—thymus cancer	1.98e-05	0.00148	CbGpPWpGaD
Dipyridamole—PDE3B—GPCR downstream signaling—IL2—thymus cancer	1.98e-05	0.00148	CbGpPWpGaD
Dipyridamole—ABCC4—Platelet activation, signaling and aggregation—AKT1—thymus cancer	1.96e-05	0.00146	CbGpPWpGaD
Dipyridamole—PDE11A—GPCR downstream signaling—AKT1—thymus cancer	1.87e-05	0.00139	CbGpPWpGaD
Dipyridamole—PDE7A—GPCR downstream signaling—AKT1—thymus cancer	1.87e-05	0.00139	CbGpPWpGaD
Dipyridamole—ABCC4—Hemostasis—IL2—thymus cancer	1.86e-05	0.00139	CbGpPWpGaD
Dipyridamole—PDE4A—GPCR downstream signaling—IL2—thymus cancer	1.86e-05	0.00138	CbGpPWpGaD
Dipyridamole—PDE1A—Disease—KIT—thymus cancer	1.85e-05	0.00138	CbGpPWpGaD
Dipyridamole—ABCC5—Disease—KIT—thymus cancer	1.85e-05	0.00138	CbGpPWpGaD
Dipyridamole—PDE7A—Signaling Pathways—IL2—thymus cancer	1.85e-05	0.00137	CbGpPWpGaD
Dipyridamole—PDE11A—Signaling Pathways—IL2—thymus cancer	1.85e-05	0.00137	CbGpPWpGaD
Dipyridamole—PDE3A—Hemostasis—TP53—thymus cancer	1.84e-05	0.00137	CbGpPWpGaD
Dipyridamole—PDE1B—Immune System—KIT—thymus cancer	1.83e-05	0.00136	CbGpPWpGaD
Dipyridamole—PDE7B—Signaling by GPCR—AKT1—thymus cancer	1.82e-05	0.00135	CbGpPWpGaD
Dipyridamole—PDE3A—GPCR downstream signaling—IL2—thymus cancer	1.81e-05	0.00134	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling by GPCR—IL2—thymus cancer	1.8e-05	0.00134	CbGpPWpGaD
Dipyridamole—PDE1A—Hemostasis—TP53—thymus cancer	1.73e-05	0.00128	CbGpPWpGaD
Dipyridamole—PDE1C—Signaling Pathways—IL2—thymus cancer	1.71e-05	0.00127	CbGpPWpGaD
Dipyridamole—PDE3B—Hemostasis—AKT1—thymus cancer	1.7e-05	0.00127	CbGpPWpGaD
Dipyridamole—PDE1A—GPCR downstream signaling—IL2—thymus cancer	1.7e-05	0.00126	CbGpPWpGaD
Dipyridamole—PDE11A—Signaling by GPCR—AKT1—thymus cancer	1.69e-05	0.00126	CbGpPWpGaD
Dipyridamole—PDE7A—Signaling by GPCR—AKT1—thymus cancer	1.69e-05	0.00126	CbGpPWpGaD
Dipyridamole—PDE1B—Disease—KIT—thymus cancer	1.69e-05	0.00126	CbGpPWpGaD
Dipyridamole—PDE6G—Signaling Pathways—IL2—thymus cancer	1.69e-05	0.00125	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling by GPCR—IL2—thymus cancer	1.69e-05	0.00125	CbGpPWpGaD
Dipyridamole—PDE6B—Signaling Pathways—TP53—thymus cancer	1.68e-05	0.00125	CbGpPWpGaD
Dipyridamole—PDE6A—Signaling Pathways—TP53—thymus cancer	1.68e-05	0.00125	CbGpPWpGaD
Dipyridamole—PDE10A—GPCR downstream signaling—AKT1—thymus cancer	1.66e-05	0.00124	CbGpPWpGaD
Dipyridamole—PDE10A—Signaling Pathways—IL2—thymus cancer	1.64e-05	0.00122	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling by GPCR—IL2—thymus cancer	1.64e-05	0.00122	CbGpPWpGaD
Dipyridamole—PDE1B—Hemostasis—TP53—thymus cancer	1.58e-05	0.00117	CbGpPWpGaD
Dipyridamole—PDE1C—Signaling by GPCR—AKT1—thymus cancer	1.57e-05	0.00117	CbGpPWpGaD
Dipyridamole—PDE1B—GPCR downstream signaling—IL2—thymus cancer	1.55e-05	0.00116	CbGpPWpGaD
Dipyridamole—PDE3A—Hemostasis—AKT1—thymus cancer	1.55e-05	0.00115	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling by GPCR—IL2—thymus cancer	1.54e-05	0.00115	CbGpPWpGaD
Dipyridamole—PDE1A—Immune System—CD4—thymus cancer	1.53e-05	0.00114	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling Pathways—KIT—thymus cancer	1.51e-05	0.00112	CbGpPWpGaD
Dipyridamole—PDE10A—Signaling by GPCR—AKT1—thymus cancer	1.51e-05	0.00112	CbGpPWpGaD
Dipyridamole—PDE1A—Hemostasis—AKT1—thymus cancer	1.46e-05	0.00108	CbGpPWpGaD
Dipyridamole—PDE1C—Immune System—AKT1—thymus cancer	1.43e-05	0.00107	CbGpPWpGaD
Dipyridamole—PDE8B—Signaling Pathways—TP53—thymus cancer	1.43e-05	0.00106	CbGpPWpGaD
Dipyridamole—PDE8A—Signaling Pathways—TP53—thymus cancer	1.43e-05	0.00106	CbGpPWpGaD
Dipyridamole—PDE6A—Signaling Pathways—AKT1—thymus cancer	1.42e-05	0.00106	CbGpPWpGaD
Dipyridamole—PDE6B—Signaling Pathways—AKT1—thymus cancer	1.42e-05	0.00106	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling Pathways—KIT—thymus cancer	1.42e-05	0.00105	CbGpPWpGaD
Dipyridamole—ABCC5—Disease—CD4—thymus cancer	1.41e-05	0.00105	CbGpPWpGaD
Dipyridamole—PDE1A—Disease—CD4—thymus cancer	1.41e-05	0.00105	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling by GPCR—IL2—thymus cancer	1.41e-05	0.00105	CbGpPWpGaD
Dipyridamole—PDE1A—Immune System—IL2—thymus cancer	1.41e-05	0.00105	CbGpPWpGaD
Dipyridamole—PDE1B—Immune System—CD4—thymus cancer	1.4e-05	0.00104	CbGpPWpGaD
Dipyridamole—PDE2A—Signaling Pathways—TP53—thymus cancer	1.39e-05	0.00104	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—KIT—thymus cancer	1.38e-05	0.00102	CbGpPWpGaD
Dipyridamole—PDE1B—Hemostasis—AKT1—thymus cancer	1.33e-05	0.000991	CbGpPWpGaD
Dipyridamole—PDE1C—Disease—AKT1—thymus cancer	1.32e-05	0.000985	CbGpPWpGaD
Dipyridamole—PDE1A—Innate Immune System—AKT1—thymus cancer	1.31e-05	0.000976	CbGpPWpGaD
Dipyridamole—PDE6G—Disease—AKT1—thymus cancer	1.31e-05	0.000972	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—KIT—thymus cancer	1.29e-05	0.000963	CbGpPWpGaD
Dipyridamole—PDE1B—Disease—CD4—thymus cancer	1.29e-05	0.000962	CbGpPWpGaD
Dipyridamole—PDE1B—Immune System—IL2—thymus cancer	1.29e-05	0.000959	CbGpPWpGaD
Dipyridamole—PDE7B—Signaling Pathways—TP53—thymus cancer	1.27e-05	0.000948	CbGpPWpGaD
Dipyridamole—PDE8B—Signaling Pathways—AKT1—thymus cancer	1.21e-05	0.000898	CbGpPWpGaD
Dipyridamole—PDE8A—Signaling Pathways—AKT1—thymus cancer	1.21e-05	0.000898	CbGpPWpGaD
Dipyridamole—PDE1B—Innate Immune System—AKT1—thymus cancer	1.2e-05	0.000893	CbGpPWpGaD
Dipyridamole—ABCC4—Hemostasis—TP53—thymus cancer	1.2e-05	0.00089	CbGpPWpGaD
Dipyridamole—PDE7A—Signaling Pathways—TP53—thymus cancer	1.18e-05	0.000881	CbGpPWpGaD
Dipyridamole—PDE11A—Signaling Pathways—TP53—thymus cancer	1.18e-05	0.000881	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—KIT—thymus cancer	1.18e-05	0.000881	CbGpPWpGaD
Dipyridamole—PDE2A—Signaling Pathways—AKT1—thymus cancer	1.18e-05	0.000875	CbGpPWpGaD
Dipyridamole—PDE1C—Signaling Pathways—TP53—thymus cancer	1.1e-05	0.000817	CbGpPWpGaD
Dipyridamole—PDE6G—Signaling Pathways—TP53—thymus cancer	1.08e-05	0.000806	CbGpPWpGaD
Dipyridamole—PDE7B—Signaling Pathways—AKT1—thymus cancer	1.08e-05	0.0008	CbGpPWpGaD
Dipyridamole—PDE3B—GPCR downstream signaling—AKT1—thymus cancer	1.08e-05	0.0008	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling Pathways—IL2—thymus cancer	1.06e-05	0.000791	CbGpPWpGaD
Dipyridamole—PDE10A—Signaling Pathways—TP53—thymus cancer	1.06e-05	0.000785	CbGpPWpGaD
Dipyridamole—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—thymus cancer	1.03e-05	0.000769	CbGpPWpGaD
Dipyridamole—ABCC4—Hemostasis—AKT1—thymus cancer	1.01e-05	0.000751	CbGpPWpGaD
Dipyridamole—PDE4A—GPCR downstream signaling—AKT1—thymus cancer	1.01e-05	0.000749	CbGpPWpGaD
Dipyridamole—PDE11A—Signaling Pathways—AKT1—thymus cancer	1e-05	0.000744	CbGpPWpGaD
Dipyridamole—PDE7A—Signaling Pathways—AKT1—thymus cancer	1e-05	0.000744	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling Pathways—IL2—thymus cancer	9.96e-06	0.000741	CbGpPWpGaD
Dipyridamole—PDE3A—GPCR downstream signaling—AKT1—thymus cancer	9.8e-06	0.000729	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling by GPCR—AKT1—thymus cancer	9.77e-06	0.000726	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—IL2—thymus cancer	9.69e-06	0.000721	CbGpPWpGaD
Dipyridamole—PDE1C—Signaling Pathways—AKT1—thymus cancer	9.28e-06	0.00069	CbGpPWpGaD
Dipyridamole—PDE1A—GPCR downstream signaling—AKT1—thymus cancer	9.21e-06	0.000685	CbGpPWpGaD
Dipyridamole—PDE6G—Signaling Pathways—AKT1—thymus cancer	9.15e-06	0.00068	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling by GPCR—AKT1—thymus cancer	9.15e-06	0.00068	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—IL2—thymus cancer	9.11e-06	0.000678	CbGpPWpGaD
Dipyridamole—PDE10A—Signaling Pathways—AKT1—thymus cancer	8.92e-06	0.000663	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling by GPCR—AKT1—thymus cancer	8.9e-06	0.000662	CbGpPWpGaD
Dipyridamole—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—thymus cancer	8.73e-06	0.000649	CbGpPWpGaD
Dipyridamole—PDE1B—GPCR downstream signaling—AKT1—thymus cancer	8.42e-06	0.000627	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling by GPCR—AKT1—thymus cancer	8.37e-06	0.000622	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—IL2—thymus cancer	8.33e-06	0.00062	CbGpPWpGaD
Dipyridamole—ADA—Metabolism—AKT1—thymus cancer	8.13e-06	0.000605	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling by GPCR—AKT1—thymus cancer	7.65e-06	0.000569	CbGpPWpGaD
Dipyridamole—PDE1A—Immune System—AKT1—thymus cancer	7.64e-06	0.000568	CbGpPWpGaD
Dipyridamole—ABCC5—Disease—AKT1—thymus cancer	7.06e-06	0.000525	CbGpPWpGaD
Dipyridamole—PDE1A—Disease—AKT1—thymus cancer	7.06e-06	0.000525	CbGpPWpGaD
Dipyridamole—PDE1B—Immune System—AKT1—thymus cancer	6.99e-06	0.00052	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling Pathways—TP53—thymus cancer	6.83e-06	0.000508	CbGpPWpGaD
Dipyridamole—PDE1B—Disease—AKT1—thymus cancer	6.45e-06	0.00048	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling Pathways—TP53—thymus cancer	6.4e-06	0.000476	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—TP53—thymus cancer	6.22e-06	0.000463	CbGpPWpGaD
Dipyridamole—ABCC5—Metabolism—AKT1—thymus cancer	5.91e-06	0.000439	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—TP53—thymus cancer	5.85e-06	0.000435	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling Pathways—AKT1—thymus cancer	5.77e-06	0.000429	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling Pathways—AKT1—thymus cancer	5.4e-06	0.000402	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—TP53—thymus cancer	5.35e-06	0.000398	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—AKT1—thymus cancer	5.26e-06	0.000391	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—AKT1—thymus cancer	4.94e-06	0.000367	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—AKT1—thymus cancer	4.52e-06	0.000336	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—AKT1—thymus cancer	1.62e-06	0.000121	CbGpPWpGaD
